Dr. Peter Grandsard
Dr. Grandsard is Executive Director of Research, Amgen, where he is responsible for the characterization of pre-clinical therapeutic candidates. Since joining Amgen in 1996, he has had a variety of roles and responsibilities. Trained as a chemical engineer (BE/ME) and as an analytical chemist (Ph.D.), he started as a scientist designing and implementing new laboratory automation and instrumentation. He led a team of engineers, physicists, biologists and chemists to increase therapeutics discovery and development efficiency, or to enable new activities. In 2011, Peter led Discovery Attribute Sciences in analyzing therapeutic candidates and reagents, biologics or synthetics, in order to understand their structures, their physical-chemical attributes, and their protein target binding properties. Peter follows evolution in instrumentation and information technologies very closely and is currently focusing on machine learning.